Skip to main content
Figure 5 | Critical Care

Figure 5

From: Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study

Figure 5

Oxidative burst activity in patients with acute heart failure or septic shock treated with levosimendan. Basal oxidative burst and oxidative burst after one hour and two hours of levosimendan infusion in (a) unstimulated, (b) N-formyl-Met-Leu-Phe (fMLP) and (c) phorbol 12-myristate 13-acetate (PMA) stimulated polymorphonuclear leukocytes (PMN) in patients with septic cardiac failure (n = 9) and patients with acute heart failure (n = 16); Graph shows box plots (median and inter quartile range); RFU, relative fluorescence units; * P < 0.05, ** P < 0.01.

Back to article page

Critical Care

ISSN: 1364-8535